-
1.发明申请MULTI-DOMAIN APPLICATIONS WITH AUTHORIZATION AND AUTHENTICATION IN CLOUD ENVIRONMENT 有权具有云环境授权和认证的多域应用程序公开(公告)号：US20150188906A1
公开(公告)日：2015-07-02
申请号：US14141495
申请日：2013-12-27
申请人： JASEN MINOV , Milen Manov , Stefan Petrov
发明人： JASEN MINOV , Milen Manov , Stefan Petrov
IPC分类号： H04L29/06
CPC分类号： H04L63/0815 , H04L63/062 , H04L63/10
摘要： A multi-domain application requiring SSO and SLO operations in cloud environment is presented. The computing system of the multi-domain application includes a multi-domain service (MDS) to redirect the calls for the multi-domain application to an identity provider to authenticate the user or to invoke the single logout services (SLOs) on the domains of the multi-domain application and to invalidate the user sessions on the domains. A cookie that includes the multi-domain application URL is generated to reach the assertion consumer service (ASC) and the single logout service (SLO) that receive an identity assertion response from the identity provider. Domain specific SLOs are provided. A trust between these domain specific SLOs and the SLO is provided based on service provider keys. The SAML mechanism for a logout scenario is reused for communication between the SLO and the domain specific SLOs, where the SLO plays a role of a local IDP.
摘要翻译： 介绍了在云环境中需要SSO和SLO操作的多域应用。 多域应用的计算系统包括多域服务（MDS），用于将多域应用的呼叫重定向到身份提供商以对用户进行身份验证或者在域的域上调用单个注销服务（SLO） 多域应用程序并使域上的用户会话无效。 生成包含多域应用程序URL的cookie以到达从身份提供者接收身份断言响应的断言消费者服务（ASC）和单个注销服务（SLO）。 提供域特定的SLO。 基于服务提供商密钥提供这些域特定SLO和SLO之间的信任。 用于注销场景的SAML机制被重用于SLO和特定于SLO的域之间的通信，其中SLO扮演本地IDP的角色。
-
2.发明授权Multi-domain applications with authorization and authentication in cloud environment 有权在云环境中具有授权和认证的多域应用程序公开(公告)号：US09386007B2
公开(公告)日：2016-07-05
申请号：US14141495
申请日：2013-12-27
申请人： Jasen Minov , Milen Manov , Stefan Petrov
发明人： Jasen Minov , Milen Manov , Stefan Petrov
IPC分类号： H04L29/06
CPC分类号： H04L63/0815 , H04L63/062 , H04L63/10
摘要： A multi-domain application requiring SSO and SLO operations in cloud environment is presented. The computing system of the multi-domain application includes a multi-domain service (MDS) to redirect the calls for the multi-domain application to an identity provider to authenticate the user or to invoke the single logout services (SLOs) on the domains of the multi-domain application and to invalidate the user sessions on the domains. A cookie that includes the multi-domain application URL is generated to reach the assertion consumer service (ACS) and the single logout service (SLO) that receive an identity assertion response from the identity provider. Domain specific SLOs are provided. A trust between these domain specific SLOs and the SLO is provided based on service provider keys. The SAML mechanism for a logout scenario is reused for communication between the SLO and the domain specific SLOs, where the SLO plays a role of a local IDP.
摘要翻译： 介绍了在云环境中需要SSO和SLO操作的多域应用。 多域应用的计算系统包括多域服务（MDS），用于将多域应用的呼叫重定向到身份提供商以对用户进行身份验证或者在域的域上调用单个注销服务（SLO） 多域应用程序并使域上的用户会话无效。 生成包含多域应用程序URL的cookie以到达从身份提供者接收身份断言响应的断言消费者服务（ACS）和单个注销服务（SLO）。 提供域特定的SLO。 基于服务提供商密钥提供这些域特定SLO和SLO之间的信任。 用于注销场景的SAML机制被重用于SLO和特定于SLO的域之间的通信，其中SLO扮演本地IDP的角色。
-
公开(公告)号：US20110135602A1
公开(公告)日：2011-06-09
申请号：US12735882
申请日：2008-12-02
摘要： The invention relates to suppressor of the endogenous human interferon-gamma (hlFN-γ) applicable in treatment of diseases associated with impaired activity of endogenous hlFN-γ, especially autoimmune diseases and for prevention of graft arteriosclerosis and rejection of organs in allograft transplanted patients. It is based on inactive analogues of the hlFN-γ with pre-served affinity to the hlFN-γ receptor, genetically modified in the domain responsible for triggering the signal transduction pathway.
摘要翻译： 本发明涉及内源性人干扰素-γ（hlFN-γ）的抑制剂，其适用于治疗与内源性hILF-γ的活性受损，特别是自身免疫性疾病相关的疾病，以及用于预防移植物移植患者的移植物动脉硬化和器官排斥。 它基于具有对hILF-γ受体的预先亲和力的hILF-γ的无活性类似物，在负责触发信号转导途径的结构域中被遗传修饰。
-
公开(公告)号：US20140212383A1
公开(公告)日：2014-07-31
申请号：US14243861
申请日：2014-04-02
IPC分类号： C07K14/57
CPC分类号： C07K14/57 , A61K38/00 , A61K38/217
摘要： The invention relates to suppressors of endogenous human interferon-gamma (INF-γ) applicable in treatment of diseases associated with impaired activity of endogenous IFN-γ. The suppressors of the invention are useful in treating autoimmune diseases and for prevention of graft arteriosclerosis and rejection of organs in allograft transplanted patients. The invention includes inactive analogues or variants of IFN-γ having preserved affinity to the IFN-γ receptor, genetically modified in the domain responsible for triggering the signal transduction pathway.
摘要翻译： 本发明涉及适用于治疗与内源性IFN-γ活性受损有关的疾病的内源性人干扰素-γ（INF-γ）抑制剂。 本发明的抑制剂可用于治疗自体免疫疾病和预防移植物移植患者的移植物动脉硬化和器官排斥。 本发明包括对负责触发信号转导途径的结构域经遗传修饰的IFN-γ受体具有保护亲和性的无活性类似物或变体。
-
-
-
搜索结果
4 条记录 (耗时 0.018 秒)
